What the study is
Wang and colleagues published “IGFBP5 alleviates periodontitis by reversing human dental follicle stem cell senescence via the non-canonical Wnt pathway” in the International Journal of Oral Science (2026;18:63, doi:10.1038/s41368-026-00463-2, published 15 September 2026, open access). The group is from the State Key Laboratory of Oral Diseases at West China Hospital of Stomatology, Sichuan University, with co-authors at the University of Hong Kong and Kunming Medical University. The premise is a supply problem for cell therapy in periodontitis: dental follicle stem cells, a core part of the adult periodontal stem cell pool, lose fitness as they senesce, and the paper asks whether one downregulated gene, IGFBP5, is an actionable driver of that decline. This is a stem cell and periodontal repair study, not an organoid study; it connects at one remove to the tooth root organoid program, whose open problems include periodontal integration of lab-built constructs, and this piece keeps the two separate.
What was measured in cells
Human dental follicle stem cells came from third molars of healthy donors under 18, and rat dental follicle stem cells from neonatal Sprague-Dawley rats. Senescence was induced two ways: 150 micromol/L hydrogen peroxide for 24 hours (oxidative stress senescence), or serial passaging to passage 12 against passage 3 young controls (replicative senescence). RNA sequencing found 1,978 differentially expressed genes in the oxidative group and 2,764 in the replicative group versus young cells, and IGFBP5 was among the most senescence-sensitive: down more than 5-fold in oxidative stress senescence and 69-fold in replicative senescence, at both mRNA and protein level. Lentiviral overexpression of IGFBP5 in these stressed cells reduced senescence-associated beta-galactosidase staining, rescued hydrogen peroxide-induced loss of viability, reversed G0/G1 cell cycle arrest, and preserved osteogenic differentiation potential. Knockdown had the opposite effect, increasing senescent cells.
The Wnt mechanism
To find the pathway, the authors ran RNA-seq on senescent cells with and without IGFBP5 overexpression. Non-canonical Wnt markers, WNT5B, c-Jun, and phospho-c-Jun, fell with overexpression, while canonical Wnt components, beta-catenin, phospho-beta-catenin, and phospho-GSK3beta, did not change. The paper’s reading is that IGFBP5 acts through dampening the non-canonical Wnt arm, with WNT5B as a candidate key regulator, rather than through the canonical beta-catenin route that much of third dentition signaling research centers on.
What the rat model showed
For delivery, the cells were loaded into a gelatin methacryloyl hydrogel carrying vinyl-modified nanohydroxyapatite (Gel-vHA). The in vivo test was a ligature-induced periodontitis model in six-week-old male Sprague-Dawley rats: the maxillary second molar was ligated for one month, then rats received treatment and were sacrificed on day 30, with micro-CT readout four weeks post-treatment. There were five arms (n=6 each): healthy control, PBS, cell-free Gel-vHA, Gel-vHA with unmodified dental follicle stem cells, and Gel-vHA with IGFBP5-overexpressing cells. The overexpression arm had the smallest cementoenamel-junction-to-bone-crest distance, closest to healthy controls, and the highest bone mineral density and bone volume fraction of any treatment group, with matching histology on H&E sections. Sequencing data are deposited in SRA project PRJNA1480452.
Boundary and what it changes
Every in vivo claim is from one small-animal model: male rats, n=6 per arm, a single timepoint, with no large-animal or human data. The human side of the paper is in vitro only, and senescence there was induced experimentally with peroxide or passaging, not taken from aged patients. The authors themselves name the gaps in their stated next steps: a formulation suited to minimally invasive intraoral injection, and long-term safety and efficacy in large-animal periodontal defect models. The clinical backdrop they cite is the 2025 multicenter randomized trial of allogeneic dental pulp stem cell injection for periodontitis in China (Liu et al., Signal Transduction and Targeted Therapy 10:239), which shows the delivery concept is being tested in patients, but nothing in today’s paper is a patient result. For the root organoid program, the import is adjacent: it is evidence about rejuvenating the developmental stem cell population that builds the periodontium, and about a Wnt-branch choice, not about integrating a self-assembled root with its supporting tissues. The field assessment at /field/ does not change on this record.
Provenance: grounded in the full open-access text of Wang et al. (2026), International Journal of Oral Science 18:63, doi:10.1038/s41368-026-00463-2; sequencing data in SRA PRJNA1480452. See /method/.